Insulet Announces Full Market Release of Omnipod 5 Automated Insulin Delivery System

Hitesh
thehealthco

The Omnipod 5 Automated Insulin Delivery (AID) System (Omnipod 5) is now completely available through U.S. retail pharmacy channels for people with type 1 diabetes aged six and older, according to Insulet Corporation, the industry pioneer in tubeless insulin pump technology.

“With the significant demand for our tubeless AID system and impressive clinical outcomes, we continue to expand access to Omnipod 5 and provide a best-in-class experience to more people with type 1 diabetes”, “Through our team’s learnings from the limited market release, we have met our timeframe and goals. We are thrilled to announce that Omnipod 5 is now fully available through retail, specialty, and mail-order pharmacies to anyone with a prescription and coverage.”

Bret Christensen, Insulet Chief Commercial Officer

The Dexcom G6 CGM system and Omnipod 5 are the first tubeless AID systems to work together in the United States to assist guard against high and low glucose levels1. It is also the only tubeless AID that provides users with the choice of using an independent Omnipod 5 Controller or a compatible smartphone2. To make this option accessible to as many individuals with diabetes as possible, Insulet is continuing to increase the number of devices that are compatible with it.

“Omnipod 5 has been such a life-changing technology. My patients and I have seen significant improvement of their time in range with no overnight lows and much less work required”, “It has given parents and other caregivers more peace of mind, especially overnight, and that’s priceless. People no longer have to make trade-offs between outcomes and a better lifestyle fit because it’s a tubeless AID.” She continued, “Many have told me that they have been extremely happy with Omnipod 5 and are feeling a new sense of freedom. I can see why there has been tremendous demand for this product!”

Dr. Anita Swamy, Medical Director, Chicago Children’s Diabetes Center

 

“Having been on insulin pens for decades, I’ve had to deal with the roller coaster of blood sugar levels. Since starting Omnipod 5 as my first insulin pump, my glucose spikes have disappeared and it’s the first time in my life I’ve had weeks of consistent 80%+ time in range.” He can’t remember the last time he had a low blood sugar, and that his energy and focus have also significantly improved. “It has changed my life,”

Marston Alfred who made the switch to Omnipod 5 from multiple daily injections

The only insulin pumps offered through the pharmacy channel are the Omnipod 5 and Omnipod DASH, which remove the high upfront cost and four-year lock-in term common with the standard Durable Medical Equipment (DME) channel and make it easier for patients with type 1 diabetes to access.

In addition to its continuing digital and social marketing, Insulet has launched new direct-to-consumer TV advertising to raise awareness of Omnipod 5, the first tubeless AID system in the United States.

Next Post

Renegade.bio Launches Monkeypox Test with Fast Result Turn-Around Times of 24 hours

An LGBTQ-owned public benefit corporation named Renegade.bio announced today that it has started processing highly sensitive and exact polymerase chain reaction (PCR) monkeypox tests for San Francisco and the entire state of California. Through collaborations with nearby clinics and hospitals, Renegade.bio is able to deliver test results in 24 hours. […]
thehealthco